Business · 12/11/1999

FDA Releases Guidance for Electronic Submissions of Biologics License Applications and Related Documents

The Food and Drug Administration (FDA) has made available a guidance document outlining the process for submitting biologics license applications and related documents in electronic format to the Center for Biologics Evaluation and Research (CBER). This voluntary process aims to improve efficiency in the submission of regulatory information for biological products.